RARE Latest Headlines

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

at www.tipranks.com (Mon, 7-Sep 12:21 PM)

Red Cat, USA Rare Earth, uniQure, Ultragenyx, Copart Trending

at www.tipranks.com (Sat, 5-Sep 5:01 AM)

Goldman Sachs Reaffirms Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

at www.tipranks.com (Fri, 4-Sep 6:56 AM)

Barclays Remains a Buy on Ultragenyx Pharmaceutical (RARE)

at www.tipranks.com (Fri, 4-Sep 5:26 AM)

Ultragenyx Expands Rare Muscle Pipeline With First-in-Human UX016 Trial in GNE Myopathy

at www.tipranks.com (Thu, 3-Sep 12:31 PM)

Ultragenyx slides amid multiple downgrades on trial setback for Angelman syndrome drug

at seekingalpha.com (Thu, 3-Sep 11:31 AM)

Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?

at www.tipranks.com (Thu, 3-Sep 9:29 AM)

Wedbush Keeps Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

at www.tipranks.com (Thu, 3-Sep 8:16 AM)

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

at www.tipranks.com (Thu, 3-Sep 7:50 AM)

At a glance: stocks gapping down premarket

at seekingalpha.com (Thu, 3-Sep 7:37 AM)

Canaccord Genuity Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

at www.tipranks.com (Thu, 3-Sep 6:56 AM)

Ultragenyx: GTX-102 Setback Triggers Price-Target Cut to $25, but Buy Rating Maintained on Pipeline Upside

at www.tipranks.com (Thu, 3-Sep 6:15 AM)